| 000 | 01274 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514204947.0 | ||
| 264 | 0 | _c20060207 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a1744-8328 | ||
| 024 | 7 |
_a10.1586/14737140.4.5.715 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNavari, Rudolph M | |
| 245 | 0 | 0 |
_aAprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting. _h[electronic resource] |
| 260 |
_bExpert review of anticancer therapy _cOct 2004 |
||
| 300 |
_a715-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiemetics _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aAprepitant |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMorpholines _xtherapeutic use |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 773 | 0 |
_tExpert review of anticancer therapy _gvol. 4 _gno. 5 _gp. 715-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/14737140.4.5.715 _zAvailable from publisher's website |
| 999 |
_c15175599 _d15175599 |
||